Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection (GS-US-320-1092)
To find out the effects of tenofovir alafenamide (TAF) on children and adolescents with chronic hepatitis B.
To find out the effects of tenofovir alafenamide (TAF) on children and adolescents with chronic hepatitis B.
To find out if Time Limited Eating can help teens lose weight.
Intervention Study for Type 2 Diabetes.
To assess the survival rate of subjects at 6 and 12 months following implantation of the Bioabsorbable pulmonary valve conduit. To assess the rate of conduit failures at 6 months, requiring re-intervention or reoperation.